Home > News > BioPharma India 2017 is upcoming in september
Industry Updates New Products Supplier News Upcoming Events business web

BioPharma India 2017 is upcoming in september

Hits:1114   Date: 7/20/2017

BioPharma India 2017

The move towards a more transparent regulatory regime in India is opening up its biopharma industry once again. With the widely available patient population and low manufacturing cost base, India remains an attractive destination for international biopharma players.

But there are still challenges – quality assurance and control concerns need to be addressed if India wants to supply into the world’s most lucrative international markets. R&D also needs to be strongly supported, fostering an environment of innovation and encouraging new biotech start-ups to develop cutting-edge solutions and products, and also attracting world-class talent home to India.
 
Join us in September for BioPharma India 2017, where you will have the opportunity to meet
leading biotech entrepreneurs, innovative start-ups and major pharma players from both within and outside India. Together, they create our most ambitious agenda ever, reflecting the huge opportunity in India’s biopharma industry. Happening on 19th and 20th September at Grand Hyatt Mumbai, get to hear from the movers and shakers with case studies, innovation showcases and interactive panel discussions.
 
Here are some highlights from our impressive speaker lineup:
  • Bindu Ajit, Program Director – Biocon Academy, Biocon
  • K. Bangarurajan, Dy. Drugs Controller (India), CDSCO West Zone Mumbai
  • Vikas Dandekar, Chief Editor – News, CNBC TV18
  • Sanjay Singh, Chief Executive Officer, Gennova biopharmaceuticals
  • Mayur Parmar, Senior Drug Inspector, Gujarat State FDA
  • Suja Chandy, Vice President, Invest India
  • Jawed Zia, Country President, India, Novartis
  • Rodrigo Blanco Zamora, Trade and Investment Commissioner, ProMexico
  • S D Ravetkar, Executive Director, Serum Institute of India
  • Mahesh Bhalgat, Chief Operations Officer, Shantha Biotechnics (a Sanofi Company)
  • Dipak Thakur, General Manager, Genomics and Biotechnology, Wockhardt
With sessions exploring manufacturing, vaccines, biosimilars and biotech innovation, this is your one-stop shop to take the pulse of India’s burgeoning biopharma industry and identify the opportunities for your business.
 
Interested? Book your passes here! Quote KFCC to enjoy 15% off current rates
 
For further enquiries, feel free to contact Pinky Fadullon at pinky.fadullon@terrapinn.com or (65) 6322 2738